Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Chung Wang

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Carcinogenesis|January 12, 2013
The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancerYi-Hua Lai, Sung-Liang Yu, Hsuan-Yu Chen, et al.
Plos One|April 25, 2012
Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cellsChi-Chung Wang, Sheng-Yi Lin, Yi-Hua Lai, et al.
American Journal of Cancer Research|June 11, 2024
Effects of methylation and transcription factor YY1 on ID2 expression in non-small cell lung carcinoma cellsYi-Hsin Tseng, Wen-Ru Chou, Wei-Lun Liu, et al.
Neuro-Oncology|September 5, 2012
Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1Chii-Wen Chou, Chi-Chung Wang, Chung-Pu Wu, et al.
Cancer Research|May 19, 2007
Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1Chi-Chung Wang, Meng-Feng Tsai, Ting-Hao Dai, et al.
Journal of Cancer|May 23, 2017
HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancerChi-Jen Chang, Yen-Lin Chen, Chia-Hung Hsieh, et al.
Cancer Science|September 15, 2022
Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastomaSung-Tai Wei, Jung-Ying Chiang, Hwai-Lee Wang, et al.
Biomacromolecules|November 21, 2009
Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pyloriChiung-Hung Chang, Yu-Hsin Lin, Chia-Lin Yeh, et al.
Theranostics|April 25, 2017
Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer ProgressionYu-Jung Lin, Woei-Cherng Shyu, Chi-Wei Chang, et al.
International Journal of Biological Macromolecules|June 4, 2025
Innovative design of hyaluronic acid conjugated polymeric drug for targeted therapy of non-small cell lung cancerKuo-Wei Chen, Hau-Lun Huang, Chi-Chung Wang, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Carcinogenesis|January 12, 2013
The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancerYi-Hua Lai, Sung-Liang Yu, Hsuan-Yu Chen, et al.
Plos One|April 25, 2012
Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cellsChi-Chung Wang, Sheng-Yi Lin, Yi-Hua Lai, et al.
American Journal of Cancer Research|June 11, 2024
Effects of methylation and transcription factor YY1 on ID2 expression in non-small cell lung carcinoma cellsYi-Hsin Tseng, Wen-Ru Chou, Wei-Lun Liu, et al.
Neuro-Oncology|September 5, 2012
Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1Chii-Wen Chou, Chi-Chung Wang, Chung-Pu Wu, et al.
Cancer Research|May 19, 2007
Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1Chi-Chung Wang, Meng-Feng Tsai, Ting-Hao Dai, et al.
Journal of Cancer|May 23, 2017
HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancerChi-Jen Chang, Yen-Lin Chen, Chia-Hung Hsieh, et al.
Cancer Science|September 15, 2022
Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastomaSung-Tai Wei, Jung-Ying Chiang, Hwai-Lee Wang, et al.
Biomacromolecules|November 21, 2009
Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pyloriChiung-Hung Chang, Yu-Hsin Lin, Chia-Lin Yeh, et al.
Theranostics|April 25, 2017
Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer ProgressionYu-Jung Lin, Woei-Cherng Shyu, Chi-Wei Chang, et al.
International Journal of Biological Macromolecules|June 4, 2025
Innovative design of hyaluronic acid conjugated polymeric drug for targeted therapy of non-small cell lung cancerKuo-Wei Chen, Hau-Lun Huang, Chi-Chung Wang, et al.
Pageof 4